title: Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
authors.forename: Giulia
authors.initials: G
authors.lastname: De Angelis
authors.forename: Michela
authors.initials: M
authors.lastname: Cipriani
authors.forename: Roberto
authors.initials: R
authors.lastname: Cauda
authors.forename: Evelina
authors.initials: E
authors.lastname: Tacconelli
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017714:Community-Acquired Infections; D005060:Europe; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology*; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination